Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-Arrestin: a protein that regulates beta-adrenergic receptor function.

M J Lohse1, J L Benovic, J Codina

  • 1Howard Hughes Medical Institute, Department of Medicine, Biochemistry and Cell Biology, Durham, NC 27710.

Science (New York, N.Y.)
|June 22, 1990
PubMed
Summary

A newly identified protein, beta-arrestin, acts as a cofactor for beta-adrenergic receptor kinase (beta ARK). This interaction is crucial for homologous desensitization of beta-adrenergic receptors, a key process in cellular signaling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caspase-cleaved arrestin-2 and BID cooperatively facilitate cytochrome C release and cell death.

Cell death and differentiation·2013
Same author

Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder.

Neurobiology of disease·2011
Same author

Structural determinants in the second intracellular loop of the human cannabinoid CB1 receptor mediate selective coupling to G(s) and G(i).

British journal of pharmacology·2010
Same author

Deletion of the distal COOH-terminus of the A2B adenosine receptor switches internalization to an arrestin- and clathrin-independent pathway and inhibits recycling.

British journal of pharmacology·2010
Same author

Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia.

Neurobiology of aging·2006
Same author

Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.

Parkinsonism & related disorders·2005

Area of Science:

  • Molecular biology
  • Cell signaling
  • G protein-coupled receptor regulation

Background:

  • Homologous desensitization of beta-adrenergic receptors involves beta-adrenergic receptor kinase (beta ARK).
  • Evidence suggests a cofactor is necessary for beta ARK to inhibit receptor function.

Purpose of the Study:

  • To clone and characterize a cofactor involved in beta-adrenergic receptor desensitization.
  • To elucidate the role of this cofactor in the beta ARK-mediated signaling pathway.

Main Methods:

  • Complementary DNA (cDNA) cloning of the cofactor.
  • Expression and partial purification of the identified protein.
  • Inhibition assays to measure the effect of the purified protein on receptor signaling.

Related Experiment Videos

Main Results:

  • A 418-amino acid protein, named beta-arrestin, was cloned and found to be homologous to retinal arrestin.
  • Expressed beta-arrestin significantly inhibited the signaling of beta ARK-phosphorylated beta-adrenergic receptors (>75%).
  • Beta-arrestin did not inhibit the signaling of phosphorylated rhodopsin.

Conclusions:

  • Beta-arrestin functions as a cofactor for beta-adrenergic receptor kinase (beta ARK).
  • Beta-arrestin, in conjunction with beta ARK, mediates homologous desensitization of beta-adrenergic receptors.
  • This finding provides a molecular mechanism for receptor desensitization.